T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRO
1876
DELISTED
PROS Holdings
PRO
| $1.04M | ﹤0.01% |
36,341
+6,174
| +20% | +$196K |
|
|
DEA
1877
Easterly Government Properties
DEA
$1.18B
| $1.04M | ﹤0.01% |
33,521
+6,021
| +22% | +$178K |
|
1878
1-800-Flowers.com
FLWS
$262M
| $1.03M | ﹤0.01% |
108,502
+87,237
| +410% | +$819K |
|
1879
TripAdvisor
TRIP
$1.26B
| $1.03M | ﹤0.01% |
57,694
-396,625
| -87% | -$8.6M |
|
1880
Dana Inc
DAN
$3.26B
| $1.03M | ﹤0.01% |
84,687
+4,268
| +5% | +$55.5K |
|
1881
Empire State Realty Trust
ESRT
$817M
| $1.02M | ﹤0.01% |
108,586
+4,877
| +5% | +$45.5K |
|
|
SASR
1882
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.01M | ﹤0.01% |
41,365
+3,482
| +9% | +$77.3K |
|
1883
Deluxe
DLX
$1.09B
| $1.01M | ﹤0.01% |
44,789
+2,524
| +6% | +$53.9K |
|
1884
Triumph Financial Inc
TFIN
$1.87B
| $1M | ﹤0.01% |
12,254
+279
| +2% | +$20.8K |
|
1885
Madison Square Garden
MSGE
$4.18B
| $1M | ﹤0.01% |
29,186
+976
| +3% | +$36.1K |
|
|
ELME
1886
Elme Communities
ELME
$144M
| $998K | ﹤0.01% |
62,588
+8,048
| +15% | +$123K |
|
1887
MannKind Corp
MNKD
$1.2B
| $996K | ﹤0.01% |
190,660
+18,606
| +11% | +$84.4K |
|
1888
Collegium Pharmaceutical
COLL
$913M
| $994K | ﹤0.01% |
30,861
+1,579
| +5% | +$54.8K |
|
1889
Ginkgo Bioworks
DNA
$488M
| $991K | ﹤0.01% |
74,945
-7,511
| -9% | -$224K |
|
1890
RLJ Lodging Trust
RLJ
$1.67B
| $991K | ﹤0.01% |
102,811
-4,305
| -4% | -$45.3K |
|
1891
Syndax Pharmaceuticals
SNDX
$1.77B
| $990K | ﹤0.01% |
48,198
+3,688
| +8% | +$77.2K |
|
1892
SiriusXM
SIRI
$9.43B
| $987K | ﹤0.01% |
34,853
+407
| +1% | +$12.2K |
|
1893
Worthington Enterprises
WOR
$2.78B
| $987K | ﹤0.01% |
20,843
+1,161
| +6% | +$65.6K |
|
1894
Adeia
ADEA
$3.16B
| $986K | ﹤0.01% |
88,165
-12,188
| -12% | -$133K |
|
1895
Golar LNG
GLNG
$5.21B
| $986K | ﹤0.01% |
31,443
+3,453
| +12% | +$91.3K |
|
1896
Enviri
NVRI
$583M
| $984K | ﹤0.01% |
113,972
+6,332
| +6% | +$52.8K |
|
|
SILK
1897
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $983K | ﹤0.01% |
36,322
+1,417
| +4% | +$29.5K |
|
1898
Teladoc Health
TDOC
$1.26B
| $980K | ﹤0.01% |
100,129
+13,752
| +16% | +$168K |
|
1899
Utz Brands
UTZ
$1.25B
| $974K | ﹤0.01% |
58,502
+623
| +1% | +$11.2K |
|
1900
Chewy
CHWY
$9.2B
| $971K | ﹤0.01% |
35,627
+1,800
| +5% | +$34.3K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.